A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Fudan University
Mayo Clinic
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sun Yat-sen University
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Rutgers, The State University of New Jersey
University College Cork
Brigham and Women's Hospital
Rutgers, The State University of New Jersey
Kaiser Permanente
University of Miami
University of Colorado, Denver
Institute of Cancer Research, United Kingdom
Duke University
Dana-Farber Cancer Institute
University of Florida
Mayo Clinic
Yale University
University Hospital, Strasbourg, France
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Hackensack Meridian Health
Memorial Sloan Kettering Cancer Center
Royal North Shore Hospital
Mayo Clinic
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
University of Oklahoma
Peking University People's Hospital
UNC Lineberger Comprehensive Cancer Center
European Institute of Oncology
UNC Lineberger Comprehensive Cancer Center
Women's Hospital School Of Medicine Zhejiang University
University of Kentucky
European Institute of Oncology
Washington University School of Medicine
Gustave Roussy, Cancer Campus, Grand Paris
Medical College of Wisconsin
UNC Lineberger Comprehensive Cancer Center
University of Oklahoma